Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

Phase 3 Completed 307 enrolled Vivozon, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following abdominoplasty.

Timeline

Start: 2019-05-23
Primary completion: 2019-08-03
Completion: 2019-08-21

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VVZ-149	Small molecule	1000 mg	Intravenous

Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

Summary

Timeline

Drugs

Indications